Early research (Phase 1)Study completedNCT05706623
What this trial is testing
Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function
Who this might be right for
Hepatic Impairment
VectivBio AG 16